Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib

Brett King*, Alfred Ian Lee, Jaehyuk Choi

*Corresponding author for this work

Research output: Contribution to journalArticle

23 Scopus citations
Original languageEnglish (US)
Pages (from-to)951-954
Number of pages4
JournalJournal of Investigative Dermatology
Volume137
Issue number4
DOIs
StatePublished - Apr 1 2017

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this